Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial investigating neoadjuvant toremifene with melatonin or metformin in locally advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Open Label Immunotherapy Trial for Breast Cancer [Phase 2]
Open-label Phase 2 immunotherapy trial for breast cancer undergoing ongoing updates.
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: COGNUTRIN in Breast Cancer Survivors [EARLY_Phase 1]
Early-phase clinical trial update for COGNUTRIN in breast cancer survivors; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer [Phase 3]
Phase 3 trial comparing vinflunine plus gemcitabine to paclitaxel plus gemcitabine in advanced breast cancer was terminated with posted resu…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. [Phase 3]
Phase III trial evaluating bisphosphonates as adjuvant therapy in primary breast cancer has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: RCT of an Internet-based CBT Program for Sexuality and Intimacy Problems in Women Treated for Breast Cancer [Phase 3]
A Phase 3 randomized trial evaluated an internet-based CBT program addressing sexuality and intimacy issues in women treated for breast canc…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression [Phase 1]
Phase 1 study of ADCT-502 in HER2-expressing advanced solid tumors including breast cancer and non-small cell lung cancer has terminated wit…
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RT [NA]
Clinical trial update on cosmetic outcomes and toxicity for post-mastectomy immediate reconstruction with expanders and radiotherapy in brea…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC Participants [Phase 3]
Phase 3 clinical trial evaluating subcutaneous administration of trastuzumab (Herceptin) at home for HER2-positive early breast cancer has c…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases [Phase 2, Phase 3]
A phase 2/3 trial comparing conventional care to radioablation (stereotactic body radiotherapy) for extracranial oligometastases; status is …
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Liposomal Bupivacaine in Implant Based Breast Reconstruction [NA]
Clinical trial update for liposomal bupivacaine in implant-based breast reconstruction; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: FSRT in Breast Cancer Patients With Brain Metastases [Phase 2]
Phase 2 clinical trial update evaluating frameless stereotactic radiotherapy (FSRT) in breast cancer patients with brain metastases.
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: OptiBra Study, Optimal Postoperative Bra After Breastcancer Surgery [Phase 3]
Phase 3 trial update on OptiBra study evaluating optimal postoperative bra after breast cancer surgery; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer [Phase 3]
Phase 3 trial update evaluating an anthracycline-free, taxane-based chemotherapy regimen in HER2-negative early breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Survival Benefits of Statins in Breast Cancer Patients [Phase 3]
Phase 3 clinical trial update investigating survival benefits of statins in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update evaluating Icrucumab or Ramucirumab in combination with capecitabine for previously treated breast cancer; stu…
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction [Phase 2]
Phase 2 clinical trial evaluating selective intraoperative administration of local anesthesia in breast reconstruction for breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. [Phase 3]
Phase 3 trial assessing alpelisib plus fulvestrant in men and postmenopausal women with advanced breast cancer that progressed after aromata…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 [Phase 1, Phase 2]
Phase 1/2 trial evaluating dasatinib in combination with weekly paclitaxel for metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer [Phase 2]
Phase 2 trial investigating metronomic daily oral vinorelbine as first-line chemotherapy in advanced/metastatic HR+/HER2- breast cancer (com…
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer [Phase 2, Phase 3]
Clinical trial update for neoadjuvant Endostar with chemotherapy in Stage III breast cancer across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer [Phase 2]
A Phase 2 trial studied two dosing schedules of palbociclib with second-line endocrine therapy for ER-positive, HER2-negative advanced/metas…
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer [Phase 3]
Phase 3 trial comparing ABP 980 to trastuzumab in HER2-positive early breast cancer completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating GS-5829 in combination with fulvestrant or exemestane in advanced estrogen receptor-positive, HER2-negative bre…
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: eHealth Weight Loss Program in African American Breast Cancer Survivors [NA]
A completed clinical trial evaluating an eHealth weight loss program in African American breast cancer survivors; results posted in 2019.